Makda, M., Nathany, S., Bagga, H., Nath, S. K., Sagar, S., Verma, H., Swaminathan, A., Dua, V., Bhurani, D., Gupta, A., Bhargava, R. (2026). Revolutionizing AML MRD: Gene-level kinetics to uncover chemoresistant clones and predict relapse risk via NGS.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.252